{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:42Z","timestamp":1784408862820,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"DOI":"10.7759\/cureus.84873","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:21:11Z","timestamp":1748334071000},"source":"Crossref","is-referenced-by-count":2,"title":["A Rare Case of Methyldopa-Induced Hepatitis"],"prefix":"10.7759","author":[{"given":"Bruno","family":"Bonito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Cartucho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica F","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Ferreira Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do Ros\u00e1rio","family":"Ginga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer YS","year":"2017","unstructured":"de Boer YS, Kosinski AS, Urban TJ, et al.. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol. 2017, 15:103-112.e2. 10.1016\/j.cgh.2016.05.043","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade RJ","year":"2023","unstructured":"Andrade RJ, Aithal GP, de Boer YS, et al.. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report. J Hepatol. 2023, 79:853-66. 10.1016\/j.jhep.2023.04.033","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-203712","article-title":"\u03b1-methyldopa-induced hepatitis during the postpartum period","volume":"2014","author":"Kashkooli S","year":"2014","unstructured":"Kashkooli S, Baraty B, Kalantar J. \u03b1-methyldopa-induced hepatitis during the postpartum period. BMJ Case Rep. 2014, 2014:bcr2014203712. 10.1136\/bcr-2014-203712","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4321\/s1130-01082005001100011","article-title":"Methyldopa-induced acute toxic hepatitis [Article in Spanish]","volume":"97","author":"Fern\u00e1ndez-Marcote Menor EM","year":"2005","unstructured":"Fern\u00e1ndez-Marcote Menor EM, P\u00e9rez-Bedmar Delgado J. Methyldopa-induced acute toxic hepatitis [Article in Spanish]. Rev Esp Enferm Dig. 2005, 97:840-1. 10.4321\/s1130-01082005001100011","journal-title":"Rev Esp Enferm Dig"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.027","article-title":"Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids","volume":"15","author":"Bj\u00f6rnsson ES","year":"2017","unstructured":"Bj\u00f6rnsson ES, Bergmann O, Jonasson JG, Grondal G, Gudbjornsson B, Olafsson S. Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids. Clin Gastroenterol Hepatol. 2017, 15:1635-6. 10.1016\/j.cgh.2017.05.027","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1959","article-title":"Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports","volume":"6","author":"Bj\u00f6rnsson ES","year":"2022","unstructured":"Bj\u00f6rnsson ES, Medina-Caliz I, Andrade RJ, Lucena MI. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports. Hepatol Commun. 2022, 6:1895-909. 10.1002\/hep4.1959","journal-title":"Hepatol Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X15598909","article-title":"Drug-induced fulminant hepatic failure in pregnancy","volume":"8","author":"Firoz T","year":"2015","unstructured":"Firoz T, Webber D, Rowe H. Drug-induced fulminant hepatic failure in pregnancy. Obstet Med. 2015, 8:190-2. 10.1177\/1753495X15598909","journal-title":"Obstet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5084","article-title":"Autoimmune hepatitis-is histology conclusive?","volume":"9","author":"Beer A","year":"2021","unstructured":"Beer A, Dienes HP. Autoimmune hepatitis-is histology conclusive?. Ann Transl Med. 2021, 9:733. 10.21037\/atm-20-5084","journal-title":"Ann Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370607-a-rare-case-of-methyldopa-induced-hepatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:21:12Z","timestamp":1748334072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370607-a-rare-case-of-methyldopa-induced-hepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.84873","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}